title: Protective effect of hypercapnic acidosis in ischemia-reperfusion lung injury is attributable to upregulation of heme oxygenase-1.
abstract: Hypercapnic acidosis (HCA) has protective effects in animal models of acute lung injury, but the mechanism underlying the effect of HCA is unclear. Heme oxygenase-1 (HO-1) is an antioxidant enzyme that protects tissue from inflammation injury. We investigated whether HO-1 contributes to the protective effects of HCA in ischemia-reperfusion (IR)-induced lung injury. Typical acute lung injury in rats was successfully induced by 40 min of ischemia and 90 min of reperfusion in an isolated perfused lung model. The rat lungs were randomly assigned to the control group, IR group or IR + HCA group with or without zinc protoporphyrin IX (ZnPP), an HO-1 activity inhibitor. At the end of the experiment, bronchoalveolar lavage fluid (BALF) and lung tissues were collected to evaluate the degree of lung injury. In in vitro experiments, HO-1 siRNA transfected A549 cells were exposed to a normoxic or hypoxia-reoxygenation (H/R) environment in the presence or absence of HCA. IR caused significant increases in the pulmonary arterial pressure, lung weight to body weight and wet/dry ratios, lung weight gain, capillary filtration coefficient, lung injury scores, neutrophil infiltration, and concentrations of protein and TNF-α in the BALF. IR also induced degradation of inhibitor of nuclear factor (NF)-κB-α, increased IκB kinase (IKK)-β phosphorylation and nuclear translocation of NF-κB, and up-regulated HO-1 expression and activity. Furthermore, IR decreased Bcl-2 protein expression and increased the number of active caspase-3 stained cells. HCA treatment enhanced HO-1 expression and activity, and accordingly reduced IKK-NF-κB signaling, inhibited apoptosis, and significantly attenuated IR-induced changes. Treatment with ZnPP partially blocked the protective effect of HCA. In addition, HO-1 siRNA significantly reversed HCA-mediated inhibition of NF-κB signaling in A549 cells subjected to H/R. In conclusion, the protective effect of HCA in IR lung injury in rats was mediated in part by the anti-inflammatory and anti-apoptotic action of HO-1.
authors.affiliation: Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan.
authors.forename: Shu-Yu
authors.initials: SY
authors.lastname: Wu
authors.forename: Min-Hui
authors.initials: MH
authors.lastname: Li
authors.forename: Fu-Chang
authors.initials: FC
authors.lastname: Ko
authors.forename: Geng-Chin
authors.initials: GC
authors.lastname: Wu
authors.forename: Kun-Lun
authors.initials: KL
authors.lastname: Huang
authors.forename: Shi-Jye
authors.initials: SJ
authors.lastname: Chu
mesh_terms: D000138:Acidosis / Q000503:physiopathology*; D055371:Acute Lung Injury; D000818:Animals; D001835:Body Weight; D053148:Caspase 3 / Q000378:metabolism; D045744:Cell Line, Tumor; D006419:Heme Oxygenase (Decyclizing) / Q000378:metabolism*; D006801:Humans; D006935:Hypercapnia / Q000503:physiopathology*; D051550:I-kappa B Kinase / Q000378:metabolism; D008168:Lung / Q000473:pathology; D055370:Lung Injury / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008833:Microcirculation; D016328:NF-kappa B / Q000378:metabolism; D009929:Organ Size; D010539:Permeability; D010766:Phosphorylation; D011524:Protoporphyrins / Q000737:chemistry; D034741:RNA, Small Interfering / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000378:metabolism*; D013997:Time Factors; D015854:Up-Regulation
chemical_list: D016328:NF-kappa B; D011524:Protoporphyrins; D034741:RNA, Small Interfering; C017803:zinc protoporphyrin; D006419:Heme Oxygenase (Decyclizing); C491523:Hmox1 protein, rat; D051550:I-kappa B Kinase; C505410:Casp3 protein, rat; D053148:Caspase 3
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Apr;294(4):L632-41
references.pmid: 18203816
references.citation: Methods Mol Biol. 2000;99:369-91
references.pmid: 10909094
references.citation: J Am Soc Nephrol. 2006 May;17(5):1373-81
references.pmid: 16597687
references.citation: Br J Pharmacol. 2006 Oct;149(4):345-54
references.pmid: 16953189
references.citation: Int J Hypertens. 2012;2012:859235
references.pmid: 22518295
references.citation: Acta Pharmacol Sin. 2009 Feb;30(2):228-34
references.pmid: 19122672
references.citation: Transplantation. 2002 Jan 27;73(2):287-92
references.pmid: 11821745
references.citation: Crit Care. 2010;14(6):237
references.pmid: 21067531
references.citation: J Biol Chem. 2004 Mar 12;279(11):10677-84
references.pmid: 14688267
references.citation: Am J Respir Crit Care Med. 2000 Dec;162(6):2287-94
references.pmid: 11112153
references.citation: Crit Care Med. 2006 Jan;34(1):1-7
references.pmid: 16374149
references.citation: Free Radic Biol Med. 2009 Jul 1;47(1):1-12
references.pmid: 19362144
references.citation: J Surg Res. 2011 Apr;166(2):e157-64
references.pmid: 21227458
references.citation: N Engl J Med. 2000 May 4;342(18):1301-8
references.pmid: 10793162
references.citation: Proc Natl Acad Sci U S A. 1987 Apr;84(8):2464-8
references.pmid: 3470805
references.citation: J Nutr Biochem. 2012 Dec;23(12):1583-91
references.pmid: 22444871
references.citation: Acta Physiol (Oxf). 2012 May;205(1):61-70
references.pmid: 22353229
references.citation: Am J Pathol. 2007 Dec;171(6):1904-14
references.pmid: 17991714
references.citation: Pulm Pharmacol Ther. 2011 Feb;24(1):153-61
references.pmid: 20688185
references.citation: J Surg Res. 2011 May 15;167(2):e245-53
references.pmid: 20850789
references.citation: Am J Physiol Lung Cell Mol Physiol. 2006 Apr;290(4):L622-L645
references.pmid: 16531564
references.citation: Crit Care Med. 2012 Sep;40(9):2622-30
references.pmid: 22732277
references.citation: J Immunol. 2007 Dec 1;179(11):7840-51
references.pmid: 18025230
references.citation: Am J Respir Cell Mol Biol. 2007 Feb;36(2):175-82
references.pmid: 16980550
references.citation: Intensive Care Med. 2004 Mar;30(3):347-56
references.pmid: 14722644
references.citation: Physiol Rev. 2006 Apr;86(2):583-650
references.pmid: 16601269
references.citation: Crit Care Med. 2012 Feb;40(2):553-9
references.pmid: 21946657
references.citation: Crit Care Med. 2002 Jul;30(7):1605-9
references.pmid: 12130986
references.citation: Br J Pharmacol. 2009 May;157(2):244-51
references.pmid: 19309358